Literature DB >> 18212625

Risk factors for cardiovascular events after successful renal transplantation.

Yves F C Vanrenterghem1, Kathleen Claes, Giuseppe Montagnino, Steffen Fieuws, Bart Maes, Margarita Villa, Claudio Ponticelli.   

Abstract

BACKGROUND: Cardiovascular disease is a frequent cause of morbidity after renal transplantation. The aims of this study were to evaluate the incidence of cardiovascular events and to identify the main risk factors for cardiovascular complications and mortality in 2071 white adults with a renal transplant functioning for at least 1 year.
METHODS: Clinical events, routine biochemistry, and prescribed drugs at month 1, month 6, and yearly after transplantation were analyzed.
RESULTS: The incidence of cardiovascular events increased over time. At 15 years after transplantation, only 47% of surviving patients had not experienced any cardiovascular event. Risk factors associated with cardiovascular complications were male gender (P=0.04), age (P<0.0001), arterial hypertension before transplantation (P<0.0001), longer pretransplant dialysis (P<0.0001), cardiovascular event before transplantation (P<0.0001), older era of transplantation (P=0.0009), center-specific effect (P=0.003), posttransplant diabetes mellitus (P=0.01), increased pulse pressure after transplantation (P=0.02), intake of corticosteroids (P=0.016), intake of azathioprine (P=0.016), lower serum albumin after transplantation (P=0.004), and higher serum triglyceride levels after transplantation (P=0.007). The risk of death was increased in patients with low or elevated hematocrit, while it was minimal with values around 38%.
CONCLUSIONS: The occurrence of fatal and nonfatal cardiovascular events after successful renal transplantation not only relates to baseline cardiovascular risk factors present at transplantation, but also to immunosuppressive drugs and posttransplantation traditional and nontraditional risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212625     DOI: 10.1097/TP.0b013e318160254f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  31 in total

1.  Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Ty B Dunn; Hassan N Ibrahim; William D Payne; Srinath Chinnakotla; Erik B Finger; David E R Sutherland; Raja Kandaswamy; John S Najarian; Timothy L Pruett; Aleksandra Kukla; Richard Spong; Arthur J Matas
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

Review 3.  The genetics of kidney transplantation.

Authors:  Nicolas Pallet; Eric Thervet
Journal:  Hum Genet       Date:  2011-09-16       Impact factor: 4.132

4.  Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.

Authors:  T M Suszynski; K J Gillingham; M D Rizzari; T B Dunn; W D Payne; S Chinnakotla; E B Finger; D E R Sutherland; J S Najarian; T L Pruett; A J Matas; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

5.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

Review 6.  Minimization of steroids in kidney transplantation.

Authors:  Arthur J Matas
Journal:  Transpl Int       Date:  2008-07-24       Impact factor: 3.782

7.  Association and prognostic impact of persistent left ventricular hypertrophy after live-donor kidney transplantation: a prospective study.

Authors:  Hussein Attia Sheashaa; Tarek M Abbas; Nabil A Hassan; Khaled M Mahmoud; Amgad E El-Agroudy; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Clin Exp Nephrol       Date:  2009-10-31       Impact factor: 2.801

Review 8.  Steroid elimination-who, when, how?

Authors:  A J Matas
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

9.  Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone.

Authors:  Arthur J Matas; Kristen Gillingham; Raja Kandaswamy; Ty B Dunn; William D Payne; David E R Sutherland; Abhinav Humar
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

10.  2202 kidney transplant recipients with 10 years of graft function: what happens next?

Authors:  A J Matas; K J Gillingham; A Humar; R Kandaswamy; D E R Sutherland; W D Payne; T B Dunn; J S Najarian
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.